Lucira Health: Rises after COVID-19 test kit identifies variants

Lucira Health

09/04/2021 11:54

** Shares of medical technology company  LHDX.O  rise 15% to
$9.61 premarket
    ** Co says its molecular test kit can identify the "double
mutant" variant of COVID-19 (https://refini.tv/31Z1Mb1)
    ** "Double mutant" variant first identified in India on
March 24 and found in California on March 25 by Stanford
Clinical Virology Lab scientists - LHDX
    ** Says COVID-19 test kit reactive to at least 99.9% of all
known COVID-19 virus strains
    ** COVID-19 test kit designed to provide a result within 30
minutes from sample collection
    ** Stock has fallen ~67% since Feb 5 IPO

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))